Targeting KDM5 Demethylases: Inhibition and Degradation

被引:6
作者
Fu, Xiaoli [1 ]
Yang, Chao [2 ]
Yu, Bin [3 ]
机构
[1] Zhengzhou Univ, Coll Publ Heath, Zhengzhou 450001, Peoples R China
[2] Zhejiang Ocean Univ, Inst Innovat & Applicat, Zhoushan 316022, Zhejiang, Peoples R China
[3] Zhengzhou Univ, Sch Pharmaceut Sci, Zhengzhou 450001, Peoples R China
基金
中国博士后科学基金; 中国国家自然科学基金;
关键词
FAMILY;
D O I
10.2174/156802662004200304124340
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:261 / 263
页数:3
相关论文
共 50 条
  • [41] Differential effects of C5 inhibition, C3 inhibition, and alternative pathway inhibition on bacterial killing in vitro
    ter Avest, Mendy
    de Boer, Zenno
    Langemeijer, Saskia M. C.
    van de Kar, Nicole C. A. J.
    Jonge, Marien I. de
    ter Heine, Rob
    Langereis, Jeroen D.
    BLOOD ADVANCES, 2025, 9 (06) : 1280 - 1285
  • [42] Targeting WD Repeat-Containing Protein 5 (WDR5): A Medicinal Chemistry Perspective
    Chen, Xin
    Xu, Junjie
    Wang, Xianghan
    Long, Guanlu
    You, Qidong
    Guo, Xiaoke
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (15) : 10537 - 10556
  • [43] Cadmium interferes with the degradation of ATF5 via a post-ubiquitination step of the proteasome degradation pathway
    Uekusa, Hiroyuki
    Namimatsu, Mihoko
    Hiwatashi, Yusuke
    Akimoto, Takuya
    Nishida, Tamotsu
    Takahashi, Shigeru
    Takahashi, Yuji
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 380 (03) : 673 - 678
  • [44] mTOR Inhibition Leads to Src-Mediated EGFR Internalisation and Degradation in Glioma Cells
    Colella, Barbara
    Colardo, Mayra
    Iannone, Gianna
    Contadini, Claudia
    Saiz-Ladera, Cristina
    Fuoco, Claudia
    Barila, Daniela
    Velasco, Guillermo
    Segatto, Marco
    Di Bartolomeo, Sabrina
    CANCERS, 2020, 12 (08) : 1 - 17
  • [45] FBXO4 inhibits lung cancer cell survival by targeting Mcl-1 for degradation
    Feng, C.
    Yang, F.
    Wang, J.
    CANCER GENE THERAPY, 2017, 24 (08) : 342 - 347
  • [46] KDM5B histone demethylase controls epithelial-mesenchymal transition of cancer cells by regulating the expression of the microRNA-200 family
    Enkhbaatar, Zanabazar
    Terashima, Minoru
    Oktyabri, Dulamsuren
    Tange, Shoichiro
    Ishimura, Akihiko
    Yano, Seiji
    Suzuki, Takeshi
    CELL CYCLE, 2013, 12 (13) : 2100 - 2112
  • [47] Inhibition of TLR4 Signaling by Isorhapontigenin Targeting of the AHR Alleviates Cerebral Ischemia/Reperfusion Injury
    Liu, Jingyu
    Mu, Danyang
    Xu, Jikai
    Liu, Yueyang
    Zhang, Guijie
    Tang, Yue
    Wang, Dequan
    Wang, Feng
    Liang, Dong
    Hou, Yue
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2023, 71 (36) : 13270 - 13283
  • [48] Isorhapontigenin induced cell growth inhibition and apoptosis by targeting EGFR-related pathways in prostate cancer
    Zhu, Cuicui
    Zhu, Qingyi
    Wu, Zhaomeng
    Yin, Yingying
    Kang, Dan
    Lu, Shan
    Liu, Ping
    JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (02) : 1104 - 1119
  • [49] MicroRNA-196b-5p promotes malignant progression of colorectal cancer by targeting ING5
    Xin, He
    Wang, Chuanzhuo
    Chi, Yuan
    Liu, Zhaoyu
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [50] IRF3 enhances NF-κB activation by targeting IκBα for degradation in teleost fish
    Zhao, Xueyan
    Yan, Xiaolong
    Huo, Ruixuan
    Xu, Tianjun
    DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2020, 106